General MedicationsINTRAVENOUSStandard
LEVOTHYROXINE SODIUM
LEVOTHYROXINE SODIUM
Standard Dose
200MCG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 217066 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength POWDER;INTRAVENOUS - 200MCG/VIAL Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2023-03-24 00:00:00.
Structured Monograph
Clinical summary
Approval overview LEVOTHYROXINE SODIUM is listed in Drugs@FDA under application 217066 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEVOTHYROXINE SODIUM Form and strength POWDER;INTRAVENOUS - 200MCG/VIAL Sponsor ZYDUS PHARMS Submission history Latest submission status date: 2023-03-24 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.